Pharma Marketing Blog represents the opinions of
John Mack
Publisher of
Pharma Marketing News.
We accept advertising relevant to the interests of our members.
For more information, see:
Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
Pharma Marketing News e-Newsletter | Subscribe | Pharma Marketing Online Discussion Forum
Reports | Resources/Links | Glossary | Case Studies | Surveys | Pharma Marketing Blog
Pharma Marketing Vendor Directory | Conference Calendar | Pharma Jobs
Advertising Information | FAQs | About Us | Privacy Policy
| Also see Pharma Marketing News OpEd Pieces |
Vioxx Redux
Posted: February 18, 2005Just when you thought it was safe to go back into the water, Merck suggests that it may put Vioxx back on the market, according to an article in today's Wall Street Journal ("Merck May Return Vioxx to Market"). A reversal of the Vioxx withdrawal would be "a shocking turn of events." So, why is Merck considering doing it?